LABOR DAY SALE: BUY ONE GET ONE FREE SITEWIDE!

PT-141 (Bremelanotide)

From $52.00

Shop

PT-141 (Bremelanotide) · Research brief

Wholesale PT-141: Bulk Pricing, Testing and MOQs

57 WORDS

Short answer

Most buyers comparing wholesale PT-141 quotes are comparing the wrong number. Price per vial tells you almost nothing by itself, because two vials both labelled 10mg can hold measurably different amounts of actual bremelanotide once counterion salt and residual water are subtracted, and only one of them may have a lot-specific certificate of analysis standing behind it.

Key takeaways

  • Wholesale PT-141 is bulk bremelanotide supplied as a lyophilised powder in sealed glass vials, most commonly at 5mg or 10mg fill weights, for laboratory research use only.
  • Purity percentage and net peptide content measure different things, and only net peptide content tells you how much bremelanotide is actually in the vial.
  • Preparative HPLC purification usually leaves peptides as TFA salts, so gross label weight overstates usable peptide mass by a margin that varies with sequence and counterion load.
  • A certificate of analysis is only meaningful when it carries the exact lot number on your vial, names the testing laboratory, and includes a readable chromatogram plus mass spectrometry data.
  • Lyophilised peptide is stored long term at around minus 20 degrees Celsius, protected from light and from repeated freeze-thaw cycling.
  • Domestic stock with dispatch inside 24 hours shortens ambient exposure and removes customs as a variable on every wholesale PT-141 shipment.

Most buyers comparing wholesale PT-141 quotes are comparing the wrong number. Price per vial tells you almost nothing by itself, because two vials both labelled 10mg can hold measurably different amounts of actual bremelanotide once counterion salt and residual water are subtracted, and only one of them may have a lot-specific certificate of analysis standing behind it.

We've handled enough bulk enquiries to watch the same sequence play out. A lab shops on headline price, receives material that behaves inconsistently between assays, then reorders elsewhere at a unit cost that was cheaper all along. Every batch we release is built through small-batch solid-phase synthesis with exact amino-acid sequencing, and the analytics get published, because documentation is the only part of a wholesale PT-141 purchase a buyer can independently verify.

What is wholesale PT-141 and how is it supplied to research buyers?

Wholesale PT-141 is bulk-quantity bremelanotide supplied as a lyophilised (freeze-dried) powder in sealed, stoppered glass vials, most commonly at 5mg or 10mg fill weights, sold strictly for laboratory research use. Unit pricing falls as an order crosses supplier volume tiers, and every legitimate lot ships with a batch-matched third-party certificate of analysis.

The oversimplification worth killing early: bulk buying is not retail with a discount attached. It changes your risk profile. You're committing a whole program's worth of work to a single synthesis lot, so batch consistency, documentation and storage stability matter far more than the per-vial saving. What follows covers how bulk material is actually supplied, what genuinely moves the price, how to read a certificate of analysis without being misled, and how ordering and dispatch work.

How bulk bremelanotide is actually supplied

PT-141, chemically bremelanotide, is a synthetic cyclic heptapeptide described in the research literature as a melanocortin receptor agonist, with reported activity at the MC1R, MC3R and MC4R receptor subtypes. In bulk it arrives as a white to off-white lyophilised cake inside a sealed glass vial with a butyl rubber stopper and an aluminium crimp seal. None of that presentation is decorative. Freeze-drying strips out the water that drives peptide bond hydrolysis, and the crimp seal keeps atmospheric moisture away from a powder that is hygroscopic by nature.

Fill weights across wholesale PT-141 catalogues cluster at 5mg and 10mg per vial, with larger bulk fills available on request for facilities running extended assay programs. That figure on the label is gross fill weight. It is not net peptide, and the distinction is where most pricing confusion begins.

Storage expectations for research handling are simple enough: lyophilised peptide is held long term at around minus 20 degrees Celsius, kept out of light, and protected from repeated temperature cycling. Dry powder tolerates short ambient transit windows far better than solution does, which is exactly why wholesale PT-141 lots ship as powder rather than pre-mixed.

Our team sees more material compromised by freeze-thaw cycling in a shared lab freezer than by anything that happens during shipping.

What actually moves the price on a bulk lot

Three things set the real cost of wholesale PT-141: net peptide content, purity threshold, and batch economics. Almost everything else is packaging.

Net peptide content is the variable most quotes stay quiet about. Synthetic peptides purified by preparative HPLC (high-performance liquid chromatography) typically come off the column as trifluoroacetate (TFA) salts, and the vial also carries residual water measured by Karl Fischer titration. Subtract counterion and moisture, and the actual peptide mass in a 10mg vial commonly lands in the 70 to 90 percent range of label weight, depending on sequence and counterion load.

Here's the part most sourcing guides get wrong. Purity and net peptide content are two different measurements answering two different questions. Purity is a chromatographic ratio describing what fraction of the peptide-containing material is the target sequence. Net peptide content tells you how much peptide is in the vial at all. A lot can honestly report 99 percent purity and still be poor value per usable milligram.

Purity threshold drives cost non-linearly. Taking a lot from 98 to 99 percent usually means another preparative purification pass, and every pass sacrifices yield. Batch size is the counterweight: synthesis setup, cleavage, purification and the lyophilisation cycle all amortise across the run, which is precisely why volume tiers and minimum order quantities exist. Per-lot third-party testing is its own line item too, and suppliers quoting wholesale PT-141 without it are simply pricing a missing cost.

Vetting a supplier before you commit

Vetting a wholesale PT-141 supplier comes down to documents you can read, not claims you have to trust. Start with the certificate of analysis, and start with the lot number. A COA that doesn't carry the exact lot printed on your vial is a marketing document, not an analytical record.

A usable report contains the lot identifier, the analytical method, a legible HPLC chromatogram showing retention time and main peak area percentage, a mass spectrometry spectrum confirming the molecular weight matches bremelanotide, water content, and the name of the laboratory that ran the work. Anything thinner and the purity figure is an assertion rather than a result.

Consistency across lots is the second test, and it only reveals itself on your second or third order. Ask for the COA of a previous batch alongside the current one. Two chromatograms with matching retention times and comparable impurity profiles tell you the synthesis route is controlled rather than improvised.

Logistics matter more than buyers expect. Domestic warehouse stock with dispatch inside 24 hours removes customs delay and shortens the ambient exposure window on every shipment. Lot documentation can be reviewed on our certificates of analysis page, and the wider research catalogue sits at Real Peptides.

One hard line: material supplied at wholesale is research-use-only. It is not an FDA-approved drug product and is not supplied for human or veterinary use. Anyone with an animal health question should talk to their veterinarian, and clinical questions belong with a licensed physician.

Wholesale PT-141 suppliers: what separates them

These are the differences that surface in your data six weeks after the order lands, not on the checkout page.

Sourcing signal Weak bulk supply Strong bulk supply Bottom line for the buyer
Certificate of analysis One generic PDF reused across every lot, no lot number printed Batch-matched COA with lot ID, chromatogram, MS spectrum and the testing lab named If the lot number on the vial isn't on the paperwork, you hold no analytical record at all
Purity reporting A bare percentage on the product page with no method stated Stated method (HPLC area percent) plus the raw chromatogram image A number without a method is unverifiable and shouldn't factor into price comparison
Net peptide content Not mentioned anywhere on the listing Water content and counterion form disclosed alongside gross fill weight This is where real cost per milligram hides on wholesale PT-141 orders
MOQ and tiering Vague 'contact us' pricing with no published break points Transparent volume tiers and a clearly stated minimum order quantity Published tiers let you model program cost before committing to a single lot
Stock and dispatch Drop-shipped from overseas with variable lead times Domestic stock, dispatch within 24 hours, tracked transit Shorter transit means less ambient exposure and fewer temperature variables

What If: bulk sourcing scenarios

What if the certificate of analysis doesn't match my lot number?

Stop and request the lot-matched document before the vials go near a bench. A COA is lot-specific by definition, because purity, impurity profile and water content are properties of one synthesis run rather than of a product line. Suppliers who can't produce a matching record either didn't test that batch or are reselling material they didn't synthesise and can't trace back.

What if a wholesale PT-141 shipment arrives warm?

Document it before opening anything: photograph the outer packaging, the vials and any temperature indicator, then contact the supplier. Lyophilised powder is far more forgiving of short ambient excursions than reconstituted solution, since hydrolysis needs water to proceed. The genuine concerns are seal integrity and moisture ingress, so inspect the cake and the stopper rather than assuming heat alone ruined the lot.

What if the lyophilised cake looks cracked or shrunken?

Judge it by texture and clarity, not by shape. Transit vibration routinely cracks or partially collapses a freeze-dried cake with no consequence for the peptide, and small fills often look like a thin film rather than a solid puck. A cake that looks glassy, damp, or has visibly liquefied points to moisture ingress or seal failure, and that lot should be flagged with the supplier immediately.

What if I need volume beyond the published MOQ tiers?

Request a custom quote and plan for a lead time rather than same-day dispatch. Very large orders are typically filled by a dedicated synthesis run, so the timeline is set by cleavage, purification passes and the lyophilisation cycle instead of by shelf stock. The payoff is one consistent lot covering an entire research program.

The unglamorous truth about cheap bulk peptide pricing

Here's the honest answer: the cheapest wholesale PT-141 quote on the market is almost never the cheapest material. The saving comes from somewhere specific, and it's usually one of three places. No per-lot third-party testing. A lower purification standard that leaves more deletion sequences and truncated fragments in the powder. Or a gross fill weight quoted with no disclosure of counterion and water. None of those appear at checkout. All of them appear later as unexplained variance, and re-running an assay costs more than the discount ever saved.

Buying wholesale PT-141 well is less about negotiating price and more about refusing to compare numbers that aren't comparable. A milligram is only a milligram once someone has measured the water, disclosed the counterion form, and printed a lot number on the chromatogram. Labs that build the habit of reading the paperwork before the price tend to end up paying roughly what everyone else pays, and spending far less time wondering why last month's results won't replicate.

References

Peer-reviewed sources on PT-141 (Bremelanotide) indexed in PubMed, listed for research context. Real Peptides supplies PT-141 (Bremelanotide) for laboratory research use only.

  1. Small Effects, Questionable Outcomes: Bremelanotide for Hypoactive Sexual Desire Disorder. Journal of sex research, 2024. PMID 36809187. doi:10.1080/00224499.2023.2175192
  2. An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder. Expert opinion on pharmacotherapy, 2023. PMID 36242769. doi:10.1080/14656566.2022.2132144
  3. Bremelanotide for Treatment of Female Hypoactive Sexual Desire. Neurology international, 2022. PMID 35076581. doi:10.3390/neurolint14010006
  4. The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women. CNS spectrums, 2022. PMID 33455598. doi:10.1017/S109285292100002X
  5. Safety Profile of Bremelanotide Across the Clinical Development Program. Journal of women's health (2002), 2022. PMID 35147466. doi:10.1089/jwh.2021.0191
  6. Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide. Journal of women's health (2002), 2022. PMID 35230162. doi:10.1089/jwh.2021.0225
  7. Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in Women. Journal of sex research, 2021. PMID 33678061. doi:10.1080/00224499.2021.1885601
  8. Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedent. Drug and therapeutics bulletin, 2021. PMID 34642243. doi:10.1136/dtb.2021.000020

Questions

Bulk orders placed against existing domestic stock are picked, packed and dispatched within 24 hours, with tracked transit and the batch-matched certificate of analysis available for the lot you receive. Orders above published volume tiers may be filled from a dedicated synthesis run instead, which adds lead time for cleavage, purification and the lyophilisation cycle. Requesting the COA before payment is normal practice and any credible supplier will send it.
Bulk bremelanotide is supplied to laboratories, research facilities and qualified researchers for in-vitro and non-clinical research use only. It is not an FDA-approved drug product, and it is not supplied or labelled for human or veterinary consumption. Buyers are responsible for handling the material in line with their own institutional and jurisdictional requirements.
Three factors dominate: net peptide content after counterion and water are subtracted, the purity threshold the lot was purified to, and the size of the synthesis batch. Moving a lot from 98 to 99 percent purity typically requires an extra preparative HPLC pass that sacrifices yield, which raises unit cost. Larger batches amortise synthesis, purification and lyophilisation costs, which is why volume tiers exist in the first place.
Purity is a chromatographic ratio describing what fraction of the peptide-containing material in the vial is the target sequence, usually reported as HPLC area percent. Net peptide content describes how much actual peptide mass sits in the vial once trifluoroacetate counterion and residual water are subtracted from gross fill weight. A lot can report 99 percent purity and still deliver noticeably less usable peptide per vial than a competing lot, so both figures matter when comparing quotes.
Without a lot-specific COA there is no analytical evidence that the material in your vial is the sequence claimed, at the purity claimed. Impurity profiles from incomplete synthesis, including deletion sequences and truncated fragments, vary between runs, so a generic product-line document tells you nothing about the batch you hold. The practical consequence is unexplained assay variance that costs more to troubleshoot than the material cost saved.
Lyophilised peptide is stored long term at around minus 20 degrees Celsius, protected from light and from repeated freeze-thaw cycling. Dry powder is considerably more stable than solution because hydrolysis of the peptide backbone requires water, which freeze-drying removes. The most common source of degradation in practice is not shipping temperature but repeated warming and refreezing in a shared laboratory freezer.
No. Research-grade bremelanotide sold in bulk is supplied as a research chemical for laboratory use and is not an FDA-approved drug product. The regulatory status of a finished pharmaceutical product is granted to a specific manufactured formulation, not to a molecule, so research-grade material sits entirely outside that framework. It should never be described or used as a therapeutic.
The chromatogram shows retention time and the area percentage of the main peak relative to all detected peaks, which is where the reported purity figure comes from. Comparing chromatograms across two lots is the fastest way to judge batch consistency: matching retention times and similar impurity peak patterns indicate a controlled synthesis route. A purity number published without the underlying chromatogram cannot be independently checked.
Minimum order quantities are set by vial count rather than mass, and break points differ between suppliers, so published tiers matter more than any single advertised figure. Transparent tiering lets a lab model total program cost before committing, whereas 'contact us for pricing' with no published structure usually signals quote-by-quote margin. Volumes above the top published tier are generally handled as custom synthesis with a stated lead time.
Sometimes, and it's worth asking directly, because staying on one lot removes batch variation as a confounding variable across a long study. When the original lot is exhausted, request the new COA and compare it against the old one for retention time and impurity profile before switching. Suppliers who archive and share previous lot documentation make that comparison straightforward.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now